Citations (88)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Aynias Seid, Yilak Girma, Eseye Dereb, Meseret Kassa, Semira Nureddin, Ayenesh Abebe & Nega Berhane. (2024) Insights into the in-vitro Susceptibility and Drug–Drug Interaction Profiles Against Drug-Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates in Amhara, Ethiopia. Infection and Drug Resistance 17, pages 89-107.
Read now
Read now
Yuhui Dong, Xichao Ou, Chunfa Liu, Weixing Fan, Yanlin Zhao & Xiangmei Zhou. (2022) Diversity of glpK Gene and Its Effect on Drug Sensitivity in Mycobacterium bovis. Infection and Drug Resistance 15, pages 1467-1475.
Read now
Read now
Minghao Hu, Lei Fu, Bin Wang, Jian Xu, Shaochen Guo, Jiaojie Zhao, Yuanyuan Li, Xiaoyou Chen & Yu Lu. (2020) Genetic and Virulence Characteristics of Linezolid and Pretomanid Dual Drug-Resistant Strains Induced from Mycobacterium tuberculosis in vitro. Infection and Drug Resistance 13, pages 1751-1761.
Read now
Read now
Ilse Du Preez & Du Toit Loots. (2018) Novel insights into the pharmacometabonomics of first-line tuberculosis drugs relating to metabolism, mechanism of action and drug-resistance. Drug Metabolism Reviews 50:4, pages 466-481.
Read now
Read now
Jorge Moura de Sousa, Ana Sousa, Catarina Bourgard & Isabel Gordo. (2015) Potential for Adaptation Overrides Cost of Resistance. Future Microbiology 10:9, pages 1415-1431.
Read now
Read now
Jessica N Torres, Lynthia V Paul, Timothy C Rodwell, Thomas C Victor, Anu M Amallraja, Afif Elghraoui, Amy P Goodmanson, Sarah M Ramirez-Busby, Ashu Chawla, Victoria Zadorozhny, Elizabeth M Streicher, Frederick A Sirgel, Donald Catanzaro, Camilla Rodrigues, Maria Tarcela Gler, Valeru Crudu, Antonino Catanzaro & Faramarz Valafar. (2015) Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates. Emerging Microbes & Infections 4:1, pages 1-9.
Read now
Read now
Articles from other publishers (82)
Atadzhan E. Ergeshov, Sofya N. Andreevskaya, Tatyana G. Smirnova & Larisa N. Chernousova. (2024) Drug-Resistant Tuberculosis: Development Mechanisms and Methods of Molecular Genetic Diagnosis. Annals of the Russian academy of medical sciences 78:6, pages 609-620.
Crossref
Crossref
Inesa Navasardyan, Rita Miwalian, Aelita Petrosyan, Stephanie Yeganyan & Vishwanath Venketaraman. (2024) HIV–TB Coinfection: Current Therapeutic Approaches and Drug Interactions. Viruses 16:3, pages 321.
Crossref
Crossref
Paulo Durão, Peter Kis, Ivo M. Chelo, M. Rita Ventura & Lígia O. Martins. (2023) Environmentally Friendly Degradation and Detoxification of Rifampicin by a Bacterial Laccase and Hydrogen Peroxide. ChemBioChem 25:2.
Crossref
Crossref
E. Cebrián-Sastre, A. Chiner-Oms, R. Torres-Pérez, I. Comas, J. C. Oliveros, J. Blázquez & A. Castañeda-García. (2023) Selective Pressure by Rifampicin Modulates Mutation Rates and Evolutionary Trajectories of Mycobacterial Genomes. Microbiology Spectrum 11:4.
Crossref
Crossref
Pavithra Sampath, Manju Moorthy, Athul Menon, Lekshmi Madhav, Aishwarya Janaki, Madhavan Dhanapal, Alangudi Palaniappan Natarajan, Syed Hissar, Uma Devi Ranganathan, Gopalakrishna Ramaswamy & Ramalingam Bethunaickan. (2023) Downregulation of monocyte miRNAs: implications for immune dysfunction and disease severity in drug-resistant tuberculosis. Frontiers in Immunology 14.
Crossref
Crossref
Ana-Hermina Ghenu, André Amado, Isabel Gordo & Claudia Bank. (2023) Epistasis decreases with increasing antibiotic pressure but not temperature. Philosophical Transactions of the Royal Society B: Biological Sciences 378:1877.
Crossref
Crossref
Yesha Patel, Vijay Soni, Kyu Y. Rhee & John D. Helmann. (2023)
Mutations in
rpoB
That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility
. mBio 14:2.
Crossref
Crossref
Aleksandra Baran, Aleksandra Kwiatkowska & Leszek Potocki. (2023) Antibiotics and Bacterial Resistance—A Short Story of an Endless Arms Race. International Journal of Molecular Sciences 24:6, pages 5777.
Crossref
Crossref
Mitsunori Tohda, Ken-Ichi Oinuma, Arata Sakiyama, Taishi Tsubouchi, Mamiko Niki, Hiroki Namikawa, Kenshi Yamane, Koichi Yamada, Tetsuya Watanabe, Kazuhisa Asai, Hiroshi Kakeya, Yukihiro Kaneko & Tomoya Kawaguchi. (2023) Rifampicin exerts anti-mucoviscous activity against hypervirulent Klebsiella pneumoniae via binding to the RNA polymerase β subunit. Journal of Global Antimicrobial Resistance 32, pages 21-28.
Crossref
Crossref
Mokgerwa Zacharia Monama, Fisayo Olotu & Özlem Tastan Bishop. (2023) Investigation of Multi-Subunit Mycobacterium tuberculosis DNA-Directed RNA Polymerase and Its Rifampicin Resistant Mutants. International Journal of Molecular Sciences 24:4, pages 3313.
Crossref
Crossref
Ali A. Rabaan, Abbas Al Mutair, Hawra Albayat, Jawaher Alotaibi, Tarek Sulaiman, Mohammed Aljeldah, Basim R. Al Shammari, Amal H. Alfaraj, Mona A. Al Fares, Sara Alwarthan, Abdulwahab Z. Binjomah, Mohammed S. Alzahrani, Hatem M. Alhani, Mohammed S. Almogbel, Abdulmonem A. Abuzaid, Ghaya Alqurainees, Fatimah Al Ibrahim, Ali H. Alhaddad, Mubarak Alfaresi, Nadira Al-baghli & Saad Alhumaid. (2022) Tools to Alleviate the Drug Resistance in Mycobacterium tuberculosis. Molecules 27:20, pages 6985.
Crossref
Crossref
Kim R. Hardie & Samuel Jacob Fenn. (2022) JMM profile: rifampicin: a broad-spectrum antibiotic. Journal of Medical Microbiology 71:8.
Crossref
Crossref
Filia Stephanie, Mutiara Saragih, Usman Sumo Friend Tambunan & Teruna J. Siahaan. (2022) Structural Design and Synthesis of Novel Cyclic Peptide Inhibitors Targeting Mycobacterium tuberculosis Transcription. Life 12:9, pages 1333.
Crossref
Crossref
Xi Chen, Yuanyuan Li, Bin Wang & Yu Lu. (2022) Identification of Mutations Associated With Macozinone-Resistant in Mycobacterium Tuberculosis. Current Microbiology 79:7.
Crossref
Crossref
Anirudh Gairola, Aaron Benjamin, Joshua D. Weatherston, Jeffrey D. Cirillo & Hung‐Jen Wu. (2022) Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages. Advanced Therapeutics 5:6.
Crossref
Crossref
Alexander D. Giddey, Tariq A. Ganief, Naadir Ganief, Anastasia Koch, Digby F. Warner, Nelson C. Soares & Jonathan M. Blackburn. (2021) Cell Wall Proteomics Reveal Phenotypic Adaption of Drug-Resistant Mycobacterium smegmatis to Subinhibitory Rifampicin Exposure. Frontiers in Medicine 8.
Crossref
Crossref
Andrej Trauner, Amir Banaei-Esfahani, Sebastian M. Gygli, Philipp Warmer, Julia Feldmann, Mattia Zampieri, Sonia Borrell, Ben C. Collins, Christian Beisel, Ruedi Aebersold & Sebastien Gagneux. (2021) Expression Dysregulation as a Mediator of Fitness Costs in Antibiotic Resistance. Antimicrobial Agents and Chemotherapy 65:9.
Crossref
Crossref
Filia Stephanie, Mutiara Saragih & Usman Sumo Friend Tambunan. (2021) Recent Progress and Challenges for Drug-Resistant Tuberculosis Treatment. Pharmaceutics 13:5, pages 592.
Crossref
Crossref
Akamu J. Ewunkem, LaShunta Rodgers, Daisha Campbell, Constance Staley, Kiran Subedi, Sada Boyd & Joseph L. GravesJr.Jr.. (2021) Experimental Evolution of Magnetite Nanoparticle Resistance in Escherichia coli. Nanomaterials 11:3, pages 790.
Crossref
Crossref
Anna Allué-Guardia, Juan I. García & Jordi B. Torrelles. (2021) Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment. Frontiers in Microbiology 12.
Crossref
Crossref
Laura Cutugno, Jennifer Mc Cafferty, Jan Pané-Farré, Conor O’Byrne & Aoife Boyd. (2020) rpoB mutations conferring rifampicin-resistance affect growth, stress response and motility in Vibrio vulnificus. Microbiology 166:12, pages 1160-1170.
Crossref
Crossref
Timothy J de Wet, Kristy R Winkler, Musa Mhlanga, Valerie Mizrahi & Digby F Warner. (2020) Arrayed CRISPRi and quantitative imaging describe the morphotypic landscape of essential mycobacterial genes. eLife 9.
Crossref
Crossref
Ze-Jia Cui, Wei-Tong Zhang, Qiang Zhu, Qing-Ye Zhang & Hong-Yu Zhang. (2020) Using a Heat Diffusion Model to Detect Potential Drug Resistance Genes of Mycobacterium tuberculosis. Protein & Peptide Letters 27:8, pages 711-717.
Crossref
Crossref
Kadidiatou O. Ndjoubi, Rajan Sharma & Ahmed A. Hussein. (2020) The Potential of Natural Diterpenes Against Tuberculosis: An Updated Review. Current Pharmaceutical Design 26:24, pages 2909-2932.
Crossref
Crossref
R. Singh, S.P. Dwivedi, U.S. Gaharwar, R. Meena, P. Rajamani & T. Prasad. (2019)
Recent updates on drug resistance in
Mycobacterium tuberculosis
. Journal of Applied Microbiology 128:6, pages 1547-1567.
Crossref
Crossref
Luisa Maria Nieto Ramirez, Karina Quintero Vargas & Gustavo Diaz. (2020) Whole Genome Sequencing for the Analysis of Drug Resistant Strains of Mycobacterium tuberculosis: A Systematic Review for Bedaquiline and Delamanid. Antibiotics 9:3, pages 133.
Crossref
Crossref
Dillon Muzondiwa, Awelani Mutshembele, Rian E. Pierneef & Oleg N. Reva. (2020) Resistance Sniffer: An online tool for prediction of drug resistance patterns of Mycobacterium tuberculosis isolates using next generation sequencing data. International Journal of Medical Microbiology 310:2, pages 151399.
Crossref
Crossref
Ridhima Wadhwa, Nikita Sehgal, Naresh G, Taru Aggarwal, Saurabh Satija, Meenu Mehta, Gaurav Gupta, Dinesh K. Chellappan, Murtaza M. Tambuwala, Brain Oliver, Trudi Collet, Pawan K. Maurya, Philip M. Hansbro & Kamal Dua. 2020. Role of Oxidative Stress in Pathophysiology of Diseases. Role of Oxidative Stress in Pathophysiology of Diseases
107
124
.
AsmaGul Naz, Muhammad Ali, Muhammad Assad Aslam, Abrar Ul Haq Khan, Hamid Manzoor, Rehana Iqbal, Muhammad Ahmed Shehzad, Shahbaz Ahmad, Zubair Shaheen & Sumaira Rasul. (2019)
Influence of single‐nucleotide polymorphisms in the
IFNG
towards susceptibility to tuberculosis in a Pakistani population
. Annals of Human Genetics 83:6, pages 426-433.
Crossref
Crossref
Álvaro Chiner-Oms, Michael Berney, Christine Boinett, Fernando González-Candelas, Douglas B. Young, Sebastien Gagneux, William R. JacobsJrJr, Julian Parkhill, Teresa Cortes & Iñaki Comas. (2019) Genome-wide mutational biases fuel transcriptional diversity in the Mycobacterium tuberculosis complex. Nature Communications 10:1.
Crossref
Crossref
Noemí Yokobori, Johana Monteserin, Bárbara Rearte, Roxana Paul, Norberto Símboli, Beatriz López, Viviana Ritacco & María del Carmen Sasiain. (2019) Survival of an epidemic MDR strain of Mycobacterium tuberculosis and its non-prosperous variant within activated macrophages. Infection, Genetics and Evolution 73, pages 248-254.
Crossref
Crossref
Maria PuiuChristina Julius. (2019) Bacteriophage gene products as potential antimicrobials against tuberculosis. Biochemical Society Transactions 47:3, pages 847-860.
Crossref
Crossref
Andile H. Ngwane, Ray‐Dean Petersen, Bienyameen Baker, Ian Wiid, Ho Ning Wong & Richard K. Haynes. (2019) The evaluation of the anti‐cancer drug elesclomol that forms a redox‐active copper chelate as a potential anti‐tubercular drug. IUBMB Life 71:5, pages 532-538.
Crossref
Crossref
Nishad Matange, Sushmitha Hegde & Swapnil Bodkhe. (2019) Adaptation Through Lifestyle Switching Sculpts the Fitness Landscape of Evolving Populations: Implications for the Selection of Drug-Resistant Bacteria at Low Drug Pressures. Genetics 211:3, pages 1029-1044.
Crossref
Crossref
Zohar B. Weinstein & Muhammad H. Zaman. (2019) Evolution of Rifampin Resistance in Escherichia coli and Mycobacterium smegmatis Due to Substandard Drugs. Antimicrobial Agents and Chemotherapy 63:1.
Crossref
Crossref
K. V. Shur, O. B. Bekker, M. V. Zaichikova, D. A. Maslov, N. I. Akimova, N. V. Zakharevich, M. S. Chekalina & V. N. Danilenko. (2018) Genetic Aspects of Drug Resistance and Virulence in Mycobacterium tuberculosis. Russian Journal of Genetics 54:12, pages 1385-1396.
Crossref
Crossref
Tomasz Jagielski, Zofia Bakuła, Anna Brzostek, Alina Minias, Radosław Stachowiak, Joanna Kalita, Agnieszka Napiórkowska, Ewa Augustynowicz-Kopeć, Anna Żaczek, Edita Vasiliauskiene, Jacek Bielecki & Jarosław Dziadek. (2018) Characterization of Mutations Conferring Resistance to Rifampin in Mycobacterium tuberculosis Clinical Strains. Antimicrobial Agents and Chemotherapy 62:10.
Crossref
Crossref
Anastasia Koch, Helen Cox & Valerie Mizrahi. (2018) Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment. Current Opinion in Pharmacology 42, pages 7-15.
Crossref
Crossref
Jean Y. H. Lee, Ian R. Monk, Anders Gonçalves da Silva, Torsten Seemann, Kyra Y. L. Chua, Angela Kearns, Robert Hill, Neil Woodford, Mette D. Bartels, Birgit Strommenger, Frederic Laurent, Magali Dodémont, Ariane Deplano, Robin Patel, Anders R. Larsen, Tony M. Korman, Timothy P. Stinear & Benjamin P. Howden. (2018) Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. Nature Microbiology 3:10, pages 1175-1185.
Crossref
Crossref
Luisa Maria Nieto, Carolina Mehaffy & Karen M. Dobos. 2018. Mycobacterium - Research and Development. Mycobacterium - Research and Development.
Noemí Yokobori, Beatriz López, Johana Monteserin, Roxana Paul, Andrea Von Groll, Anandi Martin, Brenda Marquina-Castillo, Juan Carlos Palomino, Rogelio Hernández-Pando, María del Carmen Sasiain & Viviana Ritacco. (2018) Performance of a highly successful outbreak strain of Mycobacterium tuberculosis in a multifaceted approach to bacterial fitness assessment. International Journal of Medical Microbiology 308:3, pages 349-357.
Crossref
Crossref
QingBiao Wang, Yiqin Xu, Zhuoya Gu, Nian Liu, Ke Jin, Yao Li, M. James C. Crabbe & Yang Zhong. (2018) Identification of new antibacterial targets in RNA polymerase of Mycobacterium tuberculosis by detecting positive selection sites. Computational Biology and Chemistry 73, pages 25-30.
Crossref
Crossref
Victoria L. Campodónico, Dalin Rifat, Yu-Min Chuang, Thomas R. Ioerger & Petros C. Karakousis. (2018) Altered Mycobacterium tuberculosis Cell Wall Metabolism and Physiology Associated With RpoB Mutation H526D. Frontiers in Microbiology 9.
Crossref
Crossref
Dian Novita Wulandari, Jusak Nugraha & Soedarsono Soedarsono. (2018) THE DIFFERENCE OF MAP1LC3 LEVEL AS MACROPHAGE AUTOPHAGY MARKER BETWEEN RESISTANT AND SENSITIVE TUBERCULOSIS PATIENTS ON RIFAMPICIN. Indonesian Journal of Tropical and Infectious Disease 7:1, pages 6.
Crossref
Crossref
Lily, B Y M Sinaga, D Ardinata & Y Siregar. (2018)
The influence of mutation gene rpoB of
Mycobacterium tuberculosis
cluster I (507-534) on the elimination 25-desacetyl rifampicin in urine of tuberculosis subjects
. IOP Conference Series: Earth and Environmental Science 125, pages 012146.
Crossref
Crossref
Patricia Fajardo-Cavazos, Joshua D. Leehan & Wayne L. Nicholson. (2018) Alterations in the Spectrum of Spontaneous Rifampicin-Resistance Mutations in the Bacillus subtilis rpoB Gene after Cultivation in the Human Spaceflight Environment. Frontiers in Microbiology 9.
Crossref
Crossref
Jae Hong ShinMina Rho. (2018) Human Resistome Study with Metagenomic Sequencing Data. Hanyang Medical Reviews 38:2, pages 73.
Crossref
Crossref
Ayan Chatterjee, Arun Kumar Sharma, Amar Chandra Mahatha, Srijon Kaushik Banerjee, Manish Kumar, Sudipto Saha, Joyoti Basu & Manikuntala Kundu. (2018) Global mapping of MtrA-binding sites links MtrA to regulation of its targets in Mycobacterium tuberculosis. Microbiology 164:1, pages 99-110.
Crossref
Crossref
Edith Erika Machowski & Bavesh Davandra Kana. (2017) Genetic Mimetics of Mycobacterium tuberculosis and Methicillin-Resistant Staphylococcus aureus as Verification Standards for Molecular Diagnostics. Journal of Clinical Microbiology 55:12, pages 3384-3394.
Crossref
Crossref
Aditi Singh, Sonam Grover, Siddharth Sinha, Mriganko Das, Pallavi Somvanshi & Abhinav Grover. (2017)
Mechanistic Principles Behind Molecular Mechanism of Rifampicin Resistance in Mutant RNA Polymerase Beta Subunit of
Mycobacterium tuberculosis
. Journal of Cellular Biochemistry 118:12, pages 4594-4606.
Crossref
Crossref
Srinivasan Vijay, Dao N. Vinh, Hoang T. Hai, Vu T. N. Ha, Vu T. M. Dung, Tran D. Dinh, Hoang N. Nhung, Trinh T. B. Tram, Bree B. Aldridge, Nguyen T. Hanh, Do D. A. Thu, Nguyen H. Phu, Guy E. Thwaites & Nguyen T. T. Thuong. (2017) Influence of Stress and Antibiotic Resistance on Cell-Length Distribution in Mycobacterium tuberculosis Clinical Isolates. Frontiers in Microbiology 8.
Crossref
Crossref
Michael A. Reiche, Digby F. Warner & Valerie Mizrahi. (2017) Targeting DNA Replication and Repair for the Development of Novel Therapeutics against Tuberculosis. Frontiers in Molecular Biosciences 4.
Crossref
Crossref
Ameeruddin Nusrath Unissa & Luke Elizabeth Hanna. (2017) Molecular mechanisms of action, resistance, detection to the first-line anti tuberculosis drugs: Rifampicin and pyrazinamide in the post whole genome sequencing era. Tuberculosis 105, pages 96-107.
Crossref
Crossref
Rajamouli Pasula, William J. MartinIIII, Banu Rekha Kesavalu, Maher Y. Abdalla & Bradley E. Britigan. (2017) Passive transfer of interferon-γ over-expressing macrophages enhances resistance of SCID mice to Mycobacterium tuberculosis infection. Cytokine 95, pages 70-79.
Crossref
Crossref
Sebastian M. Gygli, Sonia Borrell, Andrej Trauner & Sebastien Gagneux. (2017) Antimicrobial resistance in Mycobacterium tuberculosis: mechanistic and evolutionary perspectives. FEMS Microbiology Reviews 41:3, pages 354-373.
Crossref
Crossref
Marília Masello Junqueira Franco, Márcio Garcia Ribeiro, Fernando Rogério Pavan, Marcelo Miyata, Marcos Bryan Heinemann, Antonio Francisco de Souza Filho, Rosilene Fressatti Cardoso, Aryadne Larissa de Almeida, Ricardo Ichiro Sakate & Antonio Carlos Paes. (2017) Genotyping and rifampicin and isoniazid resistance in Mycobacterium bovis strains isolated from the lymph nodes of slaughtered cattle. Tuberculosis 104, pages 30-37.
Crossref
Crossref
Davide Valentini, Martin Rao, Giovanni Ferrara, Marc Perkins, Ernest Dodoo, Alimuddin Zumla & Markus Maeurer. (2017) Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays. International Journal of Infectious Diseases 56, pages 155-166.
Crossref
Crossref
Jees Sebastian, Sharmada Swaminath, Rashmi Ravindran Nair, Kishor Jakkala, Atul Pradhan & Parthasarathi Ajitkumar. (2017)
De Novo
Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs
In Vitro
. Antimicrobial Agents and Chemotherapy 61:2.
Crossref
Crossref
Anna Rominski, Anna Roditscheff, Petra Selchow, Erik C. Böttger & Peter Sander. (2017)
Intrinsic rifamycin resistance of
Mycobacterium abscessus
is mediated by ADP-ribosyltransferase MAB_0591
. Journal of Antimicrobial Chemotherapy 72:2, pages 376-384.
Crossref
Crossref
Mireia Coscolla. 2017. Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control. Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control
95
116
.
Sonia Borrell & Andrej Trauner. 2017. Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control. Strain Variation in the Mycobacterium tuberculosis Complex: Its Role in Biology, Epidemiology and Control
263
279
.
Anil Kumar Gupta, Amit Singh & Sarman Singh. 2017. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Drug Resistance in Bacteria, Fungi, Malaria, and Cancer
263
285
.
Jody Phelan, Francesc Coll, Ruth McNerney, David B. Ascher, Douglas E. V. Pires, Nick Furnham, Nele Coeck, Grant A. Hill-Cawthorne, Mridul B. Nair, Kim Mallard, Andrew Ramsay, Susana Campino, Martin L. Hibberd, Arnab Pain, Leen Rigouts & Taane G. Clark. (2016) Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. BMC Medicine 14:1.
Crossref
Crossref
Goverdhan Surineni, Perumal Yogeeswari, Dharmarajan Sriram & Srinivas Kantevari. (2016) Click-based synthesis and antitubercular evaluation of dibenzofuran tethered thiazolyl-1,2,3-triazolyl acetamides. Bioorganic & Medicinal Chemistry Letters 26:15, pages 3684-3689.
Crossref
Crossref
Zhenkun Ma & Anthony Simon Lynch. (2016) Development of a Dual-Acting Antibacterial Agent (TNP-2092) for the Treatment of Persistent Bacterial Infections. Journal of Medicinal Chemistry 59:14, pages 6645-6657.
Crossref
Crossref
Paulo Durão, Daniela Gülereşi, João Proença & Isabel Gordo. (2016) Enhanced Survival of Rifampin- and Streptomycin-Resistant Escherichia coli Inside Macrophages. Antimicrobial Agents and Chemotherapy 60:7, pages 4324-4332.
Crossref
Crossref
I.D. Otchere, A. Asante-Poku, S. Osei-Wusu, A. Baddoo, E. Sarpong, A.H. Ganiyu, S.Y. Aboagye, A. Forson, F. Bonsu, A.I. Yahayah, K. Koram, S. Gagneux & D. Yeboah-Manu. (2016) Detection and characterization of drug-resistant conferring genes in Mycobacterium tuberculosis complex strains: A prospective study in two distant regions of Ghana. Tuberculosis 99, pages 147-154.
Crossref
Crossref
Lokesh Pulipati, Jonnalagadda Padma Sridevi, Perumal Yogeeswari, Dharmarajan Sriram & Srinivas Kantevari. (2016) Synthesis and antitubercular evaluation of novel dibenzo[ b , d ]thiophene tethered imidazo[1,2- a ]pyridine-3-carboxamides. Bioorganic & Medicinal Chemistry Letters 26:13, pages 3135-3140.
Crossref
Crossref
Qiming Li, Mingliang Zhou, Xiangyu Fan, Jianlong Yan, Weimin Li & Jianping Xie. (2016) Mycobacteriophage SWU1 gp39 can potentiate multiple antibiotics against Mycobacterium via altering the cell wall permeability. Scientific Reports 6:1.
Crossref
Crossref
Lokesh Pulipati, Perumal Yogeeswari, Dharmarajan Sriram & Srinivas Kantevari. (2016) Click-based synthesis and antitubercular evaluation of novel dibenzo[ b , d ]thiophene-1,2,3-triazoles with piperidine, piperazine, morpholine and thiomorpholine appendages. Bioorganic & Medicinal Chemistry Letters 26:11, pages 2649-2654.
Crossref
Crossref
P.A. Karpov, O.M. Demchuk, V.M. Britsun, D.I. Lytvyn, N.O. Pydiura, A.V. Rayevsky, D.A. Samofalova, S.I. Spivak, D.M. Volochnyuk, A.I. Yemets & Ya.B. Blume. (2016) New Imidazole Inhibitors of Mycobacterial FtsZ: the Way from High-Throughput Molecular Screening in Grid up to in vitro Verification. Science and innovation 12:3, pages 43-55.
Crossref
Crossref
P.A. Karpov, O.M. Demchuk, V.M. Britsun, D.I. Lytvyn, M.O. Pydiura, O.V. Rayevsky, D.O. Samofalova, S.I. Spivak, D.M. Volochnyuk, A.I. Yemets & Ya.B. Blume. (2016) New Imidazole Inhibitors of Mycobacterial FtsZ: the Way from High-Throughput Molecular Screening in Grid up to in vitro Verification. Nauka ta innovacii 12:3, pages 44-59.
Crossref
Crossref
Pradeep K Rai, Sathi Babu Chodisetti, Sajid Nadeem, Sudeep K Maurya, Uthaman Gowthaman, Weiguang Zeng, Ashok K Janmeja, David C Jackson & Javed N Agrewala. (2016) A novel therapeutic strategy of lipidated promiscuous peptide against Mycobacterium tuberculosis by eliciting Th1 and Th17 immunity of host. Scientific Reports 6:1.
Crossref
Crossref
Nedra Meftahi, Amine Namouchi, Besma Mhenni, Gerrit Brandis, Diarmaid Hughes & Helmi Mardassi. (2016)
Evidence for the critical role of a secondary site
rpoB
mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain
. Journal of Antimicrobial Chemotherapy 71:2, pages 324-332.
Crossref
Crossref
Howard E Takiff & Oscar Feo. (2015) Clinical value of whole-genome sequencing of Mycobacterium tuberculosis. The Lancet Infectious Diseases 15:9, pages 1077-1090.
Crossref
Crossref
Digby F. Warner, Anastasia Koch & Valerie Mizrahi. (2015) Diversity and disease pathogenesis in Mycobacterium tuberculosis. Trends in Microbiology 23:1, pages 14-21.
Crossref
Crossref
Michal Wozniak, Jerzy Tiuryn & Limsoon Wong. (2014) GWAMAR: Genome-wide assessment of mutations associated with drug resistance in bacteria. BMC Genomics 15:S10.
Crossref
Crossref
Giovanni Piccaro, Donatella Pietraforte, Federico Giannoni, Alessandro Mustazzolu & Lanfranco Fattorini. (2014) Rifampin Induces Hydroxyl Radical Formation in Mycobacterium tuberculosis. Antimicrobial Agents and Chemotherapy 58:12, pages 7527-7533.
Crossref
Crossref
Alice L. den Hertog, Sandra Menting, Dick van Soolingen & Richard M. Anthony. (2014)
Mycobacterium tuberculosis
Beijing Genotype Resistance to Transient Rifampin Exposure
. Emerging Infectious Diseases 20:11, pages 1932-1933.
Crossref
Crossref
Anastasia Koch & Robert John Wilkinson. (2014) The road to drug resistance in Mycobacterium tuberculosis. Genome Biology 15:11.
Crossref
Crossref
Andrej Trauner, Sonia Borrell, Klaus Reither & Sebastien Gagneux. (2014) Evolution of Drug Resistance in Tuberculosis: Recent Progress and Implications for Diagnosis and Therapy. Drugs 74:10, pages 1063-1072.
Crossref
Crossref
Meiring De Villiers. (2018) Attack of the Superbugs: The Law & Medicine of Antibiotic Resistance. SSRN Electronic Journal.
Crossref
Crossref